RCMI Coordinating Center (RCMI CC) Header Logo

Connection

Jerzy Leszczynski to Antiviral Agents

Back to Details
This is a "connection" page, showing publications Jerzy Leszczynski has written about Antiviral Agents.
Jerzy Leszczynski
Connection Strength
0.851
Antiviral Agents
  1. Ojha PK, Kar S, Krishna JG, Roy K, Leszczynski J. Therapeutics for COVID-19: from computation to practices-where we are, where we are heading to. Mol Divers. 2021 Feb; 25(1):625-659.
    View in: PubMed
    Score: 0.665
  2. Kumar V, Kar S, De P, Roy K, Leszczynski J. Identification of potential antivirals against 3CLpro enzyme for the treatment of SARS-CoV-2: A multi-step virtual screening study. SAR QSAR Environ Res. 2022 May; 33(5):357-386.
    View in: PubMed
    Score: 0.186
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

For technical support please contact support